The 100 Most Influential CEOs in Oncology in 2025 (Full List)
"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing
TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC
CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma
Highlights from ASCO GI 2026 by Wafik El-Deiry
Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma
CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer
Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera
The EURO Master Course in Pediatric Oncology: Module 2 is an intensive, multidisciplinary educational program focusing on Central Nervous System (CNS) and extracranial solid tumors in children and adolescents. Scheduled for May 19–23, 2026, in Tashkent, Uzbekistan, the course is a collaborative effort between the Princess Máxima Center for Pediatric Oncology, St. Jude Global, and […]
